Skip to content
  • Saturday, 12 September 2026
  • 6:36 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 23, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, classified psilocybin as a…

Read More
Laboratory Automation & Robotics

Verseon bets physics can take drug design beyond AI’s training data

Lana Keisha Jul 22, 2026 0

Bay Area-based pharmaceutical company Verseon has been a quiet pioneer in computational drug design since 2002, predating the widespread emergence…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jul 15, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 8, 2026 0

The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…

Read More
Neuroscience & Brain Research

Millions take omega-3 fish oil for brain health but a new study found no benefit

Rifan Muazin Jul 8, 2026 0

The American consumer market for fish oil supplements has ballooned into a billion-dollar industry, fueled by the widespread belief that…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jun 30, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Molecular & Cell Biology

The Ancient Story of Every Breath You Take: 289-Million-Year-Old Fossil Reveals Earliest Rib-Based Breathing System in Amniotes

Angie Faith Apr 23, 2026 0

The seemingly mundane act of taking a breath, a process so fundamental to life that it often goes unnoticed, is…

Read More
Biotech Innovations Unveiled: Five Product Launches, Key Partnerships, and Space Research Advancements Propel Human Health ForwardRising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical LabsImmunai’s digital ‘plumbing’ keeps AstraZeneca coming backA Paradigm Shift in Hair Growth: New Research Reveals Hair is Pulled, Not Pushed, by a Hidden Cellular Motor
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ